Common Contracts
15 similar Convertible Security Agreement contracts by Sigyn Therapeutics, Inc., Legacy Education Alliance, Inc.
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE SEPTEMBER 9, 2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS INC., a Delaware corporation (the “Company”), having its principal place of business at Historic Decatur Drive, Suite 140, San Diego, CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due May 10,2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE OCTOBER 20, 2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS INC., a Delaware corporation (the “Company”), having its principal place of business at Historic Decatur Drive, Suite 140, San Diego, CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due October 20, 2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE SEPTEMBER 30, 2021Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS, INC. (the “Company”), having its principal place of business at 8880 Rio San Diego Drive, Suite 800, San Diego, CA 92108, designated as its Original Issue Discount Senior Secured Debenture due September 30,2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE JUNE 23,2021Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS, INC. (the “Company”), having its principal place of business at 8880 Rio San Diego Drive, Suite 800, San Diego, CA 92108, designated as its Original Issue Discount Senior Secured Debenture due June 23,2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE NOVEMBER 14, 2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS INC., a Delaware corporation (the “Company”). having its principal place of business at Historic Decatur Drive, Suite 140. San Diego, CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due November 14, 2023 (this debenture, the “Debenture” and. collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE JULY 15, 2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS INC., a Delaware corporation (the “Company”). having its principal place of business at Historic Decatur Drive, Suite 140, San Diego, CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due July 15,2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE NOVEMBER 9, 2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS INC., a Delaware corporation (the “Company”). having its principal place of business at Historic Decatur Drive, Suite 140. San Diego. CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due November 9, 2023 (this debenture, the “Debenture” and. collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE NOVEMBER 21, 2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS INC., a Delaware corporation (the “Company”). having its principal place of business at Historic Decatur Drive, Suite 140. San Diego, CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due November 21, 2023 (this debenture, the “Debenture” and. collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE JUNE 22,2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS INC., a Delaware corporation (the “Company”), having its principal place of business at Historic Decatur Drive, Suite 140, San Diego, CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due June 22, 2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE JUNE 1,2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS INC., a Delaware corporation (the “Company”), having its principal place of business at Historic Decatur Drive, Suite 140, San Diego, CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due June 1,2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE AUGUST 31, 2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS INC., a Delaware corporation (the “Company”), having its principal place of business at Historic Decatur Drive, Suite 140, San Diego, CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due August 31, 2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
10% CONVERTIBLE DEBENTURE DUE [___]Convertible Security Agreement • August 25th, 2022 • Legacy Education Alliance, Inc. • Services-educational services • New York
THIS 10% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 10% Convertible Debentures of Legacy Education Alliance, Inc., a Nevada corporation (the “Company”), having its principal place of business at 1490 N.E. Pine Island Road, Suite 5D, Cape Coral, FL 33909 designated as its 10% Convertible Debenture due [___] (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
10% CONVERTIBLE DEBENTURE DUE AUGUST 8, 2023Convertible Security Agreement • August 12th, 2022 • Legacy Education Alliance, Inc. • Services-educational services • New York
THIS 10% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 10% Convertible Debentures of Legacy Education Alliance, Inc., a Nevada corporation (the “Company”), having its principal place of business at 1490 N.E. Pine Island Road, Suite 5D, Cape Coral, FL 33909 designated as its 10% Convertible Debenture due June 9, 2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
10% SENIOR SECURED CONVERTIBLE DEBENTURE DUE AUGUST 27, 2026Convertible Security Agreement • September 2nd, 2021 • Legacy Education Alliance, Inc. • Services-educational services • New York
THIS 10% SENIOR SECURED CONVERTIBLE DEBENTURE is a duly authorized and validly issued 10% Senior Secured Convertible Debenture of Legacy Education Alliance, Inc., a Nevada corporation (the “Company”), having its principal place of business at 1490 N.E. Pine Island Road, Suite 5D, Cape Coral, FL 33909, due August 27, 2026 (the “Debenture”).
10% SUBORDINATED CONVERTIBLE DEBENTURE DUE May 4, 2022Convertible Security Agreement • May 7th, 2021 • Legacy Education Alliance, Inc. • Services-educational services • New York
Now, therefore, to induce the Holder to lend money to the Company, in reliance thereon by the Holder and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged and affirmed by the Guarantor as being adequate, the Guarantor hereby covenants and expressly agrees as follows:
